Concomitant use of hydrocodone bitartrate and acetaminophen tablets with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of hydrocodone bitartrate and acetaminophen tablets and prolong opioid adverse reactions, and which may cause potentially fatal respiratory depression (see WARNINGS), particularly when an inhibitor is added after a stable dose of hydrocodone bitartrate and acetaminophen tablets is achieved
Related products Why Does This Happen
When you use a liposomal format, the strict "empty stomach" rule becomes less critical
Will The Skin Benefits Remain After I Stop Using Glutathione Injections
Swimming using primarily the arms, water walking, and gentle aquatic exercises allow cardiovascular maintenance without stressing the adductors